Search
Search Results
-
Hepatitis A virus infection
Hepatitis A is a vaccine-preventable infection caused by the hepatitis A virus (HAV). Over 150 million new infections of hepatitis A occur annually....
-
Signature of chronic hepatitis B virus infection in nails and hair
BackgroundHepatitis B virus (HBV) is detected in extrahepatic tissues of individuals with HBV infection. Whether nails and hair contain HBV has been...
-
Ledipasvir/Sofosbuvir Is Effective as Sole Treatment of Porphyria Cutanea Tarda with Chronic Hepatitis C
Background and AimsChronic hepatitis C [CHC] is a risk factor for porphyria cutanea tarda [PCT]. To assess whether ledipasvir/sofosbuvir is effective...
-
Diagnosis and Management of Hepatitis Delta Virus Infection
Hepatitis D virus (HDV) depends on hepatitis B virus (HBV) to enter and exit hepatocytes and to replicate. Despite this dependency, HDV can cause...
-
Risk factors for the mortality of hepatitis B virus-associated acute-on-chronic liver failure: a systematic review and meta-analysis
BackgroundHepatitis B virus-associated acute-on-chronic liver failure (HBV-ACLF) has been confirmed as a prevalent form of end-stage liver disease in...
-
Granulomatous hepatitis with Crohn’s disease: a case report
A 45-year-old man who was regularly followed up for Crohn’s disease (CD) and maintained clinical remission with vedolizumab (VDZ). At 37 years old,...
-
Direct-acting antiviral agent use and gastrointestinal safety in patients with chronic hepatitis C: a pharmacovigilance study based on FDA Adverse Event Reporting System
BackgroundGastrointestinal adverse drug reactions (GADRs) of direct-acting antiviral agents (DAAs) in patients with chronic hepatitis C are...
-
The relationship of maternal hepatitis B e antigen and response to vaccination of infants born to women with chronic infection
BackgroundThe relationship of maternal HBeAg and infants’ response to hepatitis B vaccine remains controversial. This study aims to observe the...
-
National hepatitis registry in Pakistan: a dire need for hepatitis surveillance and control
Hepatitis is a major public health issue in Pakistan, with an estimated 11.55% prevalence of HCV infection in the adult population. The country ranks...
-
World Hepatitis day 2021 –screening and vaccination against Hepatitis B virus in Accra, Ghana
BackgroundIn Ghana, Hepatitis B virus (HBV) infection remains a major public health threat as in many parts of the world. Even with an effective...
-
The role of KPNA2 as a monotonically changing differentially expressed gene in the diagnosis, risk stratification, and chemotherapy sensitivity of chronic hepatitis B-liver cirrhosis-hepatocellular carcinoma
PurposeChronic hepatitis B-liver cirrhosis-hepatocellular carcinoma (CLH), commonly called the “liver cancer trilogy”, is a crucial evolutionary...
-
Nutrition in Viral Hepatitis
Purpose of ReviewViral hepatitis caused by various hepatotropic viruses (Hepatitis A, B, C, and E) is common in develo** countries and continues to...
-
Changes in liver stiffness values assessed using transient elastography in chronic hepatitis B patients treated with tenofovir disoproxil fumarate: a prospective observational study
Background/AimsRegression of liver fibrosis during antiviral therapy in chronic hepatitis B (CHB) patients has been demonstrated, but data on the...
-
Successful treatment of infectious endocarditis-associated glomerulonephritis during active hepatitis C infection: a case report
BackgroundHepatitis C virus (HCV) may play a pathogenic role in several forms of immune complex glomerulonephritis (GN). We present a patient whose...
-
Does mass management of chronic hepatitis C protect the Egyptian population against fulminant coronavirus disease-2019? “Postulating a hypothesis”
Coronavirus disease (COVID-19) is caused by the pathogenic virus severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). Egypt has launched a...
-
Reduction of natural killer cells is associated with poor outcomes in patients with hepatitis B virus-related acute-on-chronic liver failure
Background and aimsNatural killer (NK) cells are critical innate effectors that respond to viral infections and contribute to immunopathology. Here,...
-
Minimal clinically important differences in health-related quality of life after treatment with direct-acting antivirals for chronic hepatitis C: ANRS CO22 HEPATHER cohort (PROQOL-HCV)
PurposePatient Reported Outcomes Quality of Life survey for HCV (PROQOL-HCV) is a specific tool developed to assess health-related quality of life...
-
Statin use and the risk of hepatocellular carcinoma among patients with chronic hepatitis B: an emulated target trial using longitudinal nationwide population cohort data
BackgroundNo randomized controlled trials have been completed to see whether statin can decrease hepatocellular carcinoma (HCC) risk in chronic...
-
Favourable outcome of acute hepatitis E infection in patients with ANCA-associated vasculitis
BackgroundHepatitis E virus (HEV) infection is a frequent cause of acute viral hepatitis. Immunocompromised patients are at increased risk for viral...
-
Relationship between gut microbiome diversity and hepatitis B viral load in patients with chronic hepatitis B
BackgroundHepatitis B virus (HBV) infection is associated with a reduced risk of develo** dyslipidemia and non-alcoholic fatty liver diseases....
